Your adjuvant development partner
We support you with the adjuvant solution for your vaccine needs
We are an industry leader in human and veterinary vaccine adjuvants. Leveraging over 80 years of expertise, our collaborations start at all stages of the vaccine manufacturing process. Our comprehensive portfolio of components accelerates the production of complete adjuvant systems. Let's create a tailored vaccine solution together.
Leading source of next-generation adjuvants
Vaccines save countless lives. We can protect even more people by building the vaccines of the future. This is only possible if we unveil new adjuvant options.
We support you with immuostimulators and adjuvant systems that fulfill the needs of your vaccines. We're partnering with world-leading scientists to unlock novel technologies. Together, we can create breakthroughs in prophylactic and therapeutic vaccine development. Our unique supply capabilities can support you from early research to large-scale, commercial production. Capitalise on our diverse portfolio and breadth of knowledge to bring the next generation of safe and effective vaccines into the world.
-
PHAD™
Versatile and effective, PHAD acts as a TLR4 agonist to activate proinflammatory cytokines and antigen-specific effector cells.
-
CAF01®
Part of our new generation of adjuvants, CAF01 is a liposomal adjuvant formulation that offers excellent long-term stability and drives both humoral and cellular immune responses.
-
CAF09b®
A novel liposomal adjuvant used in cancer immunotherapy trials, CAF09b has the capacity to facilitate the production of CD8+ T-cells.
-
Adju-Phos™
Well-established as a common component in a variety of vaccines, Adju-Phos is an aluminium-based adjuvant that induces strong Th2 immune responses.
-
3D(6-acyl)-PHAD™
Immunostimulatory and highly purified, 3D(6-acyl)-PHAD activates TLR4 to induce proinflammatory cytokines and T-cells.
-
3D-PHAD™
Highly pure, safe, and chemically stable, 3D-PHAD stimulates the immune system through the activation of TLR4, leading to the production of proinflammatory cytokines, CD4+ and CD8+ T-cells.
-
Alhydrogel™
One of the most widely used vaccine adjuvants, Alhydrogel is an aluminium-based adjuvant used in clinically-approved vaccines that can elicit effective Th2 immune responses.
-
AlhydroVet™
AlhydroVet is an aluminium hydroxide gel product specifically manufactured for use as an adjuvant in veterinary vaccines.
-
QS 21
*sample can be ordered for investigational use only* A powerful immunostimulatory saponin that acts as a potent vaccine adjuvant, QS 21 can stimulate both cell-mediated (Th1) and humoral (Th2) immune...
-
Quil-A™
A versatile immunostimulatory saponin that’s widely used as a potent veterinary adjuvant, Quil-A can work against both intra- and extra-cellular pathogens, stimulating innate and Th-mediated adaptive immune...
.jpg&mn=healthcare&w=768&xr=0&yr=0&xfp=6&yfp=6&hash=A29CEF82F5BE8078AFF6628F0576AD4019C138999FEC74AA)
Looking for a product?
Find a product now >
Vaccine delivery systems
Immunostimulators
Formulation compounds for delivery
Exceptional standards in adjuvant manufacturing
A history of supporting vaccines
Dedicated to your vaccine success
Download our adjuvants brochure here:
Supporting Literature
